Lexology April 19, 2024
Sheppard Mullin Richter & Hampton LLP

This is the second post in a two-part series on PrivacyCon’s key-takeaways for healthcare organizations. The first post focused on healthcare privacy issues.[1] This post focuses on insights and considerations relating to the use of Artificial Intelligence (“AI”) in healthcare. In the AI segment of the event, the Federal Trade Commission (“FTC”) covered: (1) privacy themes; (2) considerations for Large Language Models (“LLMs”); and (3) AI functionality.

AI Privacy Themes

The first presentation within the segment highlighted a study involving more than 10,000 participants and gauged their concerns around the intersection of AI and privacy.[2] The study uncovered four privacy themes: (1) data is at risk (the potential for misuse); (2) data is highly personal (it can be used to...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Govt Agencies, Healthcare System, Privacy / Security, Technology
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article